- $2.51bn
- $3.24bn
- $822.45m
- 89
- 50
- 13
- 49
2019 May 31st | 2020 May 31st | 2021 May 31st | 2022 May 31st | 2023 May 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 414 | 418 | 468 | 527 | 822 |
Cost of Revenue | |||||
Gross Profit | 192 | 196 | 215 | 243 | 406 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 345 | 351 | 394 | 469 | 785 |
Operating Profit | 68.8 | 67.5 | 74.2 | 58.6 | 37.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 73 | 72.3 | 75.3 | 60.2 | -22 |
Provision for Income Taxes | |||||
Net Income After Taxes | 60.2 | 59.5 | 60.9 | 48.3 | -22.9 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 60.2 | 59.5 | 60.9 | 48.3 | -22.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 60.2 | 59.5 | 60.9 | 48.3 | -22.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.569 | 0.563 | 0.568 | 0.447 | 0.115 |